We are live on
!
Find out more
ONC
BeOne Medicines Ltd
ONC
ONC
128 hedge funds and large institutions have $6.48B invested in BeOne Medicines Ltd in 2018 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 43 increasing their positions, 44 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
22% more first-time investments, than exits
New positions opened: 28 | Existing positions closed: 23
6% more capital invested
Capital invested by funds: $6.12B → $6.48B (+$354M)
4% more funds holding
Funds holding: 123 → 128 (+5)
0.81% more ownership
Funds ownership: 5.23% → 6.04% (+0.81%)
2% less repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 44
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
26% less call options, than puts
Call options by funds: $17.7M | Put options by funds: $23.9M
Holders
128
Holders Change
+5
Holders Change %
+4.07%
% of All Funds
2.93%
Holding in Top 10
9
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-18.18%
% of All Funds
0.21%
New
28
Increased
43
Reduced
44
Closed
23
Calls
$17.7M
Puts
$23.9M
Net Calls
-$6.21M
Net Calls Change
-$53.9M
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$1.09B |
| 2 |
Capital World Investors
Los Angeles,
California
|
+$230M |
| 3 |
Renaissance Technologies
New York
|
+$38.7M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$28.3M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$27.4M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$184M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$99.6M |
| 3 |
ICP
Indus Capital Partners
New York
|
-$49.5M |
| 4 |
PSCM
Prince Street Capital Management
New York
|
-$45.5M |
| 5 |
Goldman Sachs
New York
|
-$31.2M |
